A redox system for brain targeted estrogen delivery causes chronic body weight decrease in rats.
The effects of 2 redox based carriers for brain directed delivery of estradiol (CDS-E2) and ethinyl estradiol (CDS-EE) on body weight were examined in rats. A single dose of CDS-E2 (3 mg/kg) decreased weight gain in castrate rats for at least 24 days. The dose response of weight gain and LH suppression were compared 12 days and 12 to 25 after CDS-E2 and CDS-EE, respectively, in ovariectomized (OVX) rats. Weight decrease was detected at a lower dose and was significant for longer after drug treatment than LH decrease. Both compounds were more potent than equimolar estradiol or estradiol valerate in reducing weight gain. Intact rats also showed decreased weight gain but were less sensitive to CDS-E2 compared to OVX rats. The effects appeared to be estrogen specific as carrier-linked testosterone had no effect on weight. The mechanisms of sustained and potent drug effects on weight are being explored.
Estes
K S
KS
Center for Drug Design and Delivery, College of Pharmacy, University of Florida, Gainesville 32610.
Brewster
M E
ME
Bodor
N S
NS
D000818:Animals; D001835:Body Weight / Q000187:drug effects*; D001921:Brain / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004337:Drug Carriers; D004958:Estradiol / Q000008:administration & dosage* / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D008297:Male; D009919:Orchiectomy; D010052:Ovariectomy; D010084:Oxidation-Reduction; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D004337:Drug Carriers; D004997:Ethinyl Estradiol; D004958:Estradiol